Market Exclusive

Quest Diagnostics Incorporated (NYSE:DGX) reported earnings of $1.55 per share beating Walls Streets expectations.

Quest Diagnostics Incorporated (NYSE:DGX) reported Q2 2017 earnings this Morning, coming in at $1.55 per share, beating Wall Street’s estimates of $1.42 per Share. Revenue for the quarter came in at $1.94 billion in-line expectations of $1.94 billion

Analyst Coverage For Quest Diagnostics Incorporated (NYSE:DGX)
These are 7 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating .
The current consensus rating for Quest Diagnostics Incorporated (NYSE:DGX) is Buy (Score: 2.57) with a consensus target price of $108.54 , a potential (0.33% upside)Recent Insider Trading for Quest Diagnostics Incorporated (NYSE:DGX)

Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)

Recent Trading for Quest Diagnostics Incorporated (NYSE:DGX) Shares of Quest Diagnostics Incorporated closed the previous trading session at 108.18 down -1.26 -1.15% with 1,008,110 shares trading hands.

Exit mobile version